Fortis board decides to consider only Binding Offers, Faces Backlash Ruby Khatun Khatun21 April 2018 4:33 PM ISTNew Delhi: While the many offers are available on the table of Fortis, the board considering the offers has decided to take consideration only of...
Top Indian Pharma formulators eyeing OTC market: Report Ruby Khatun Khatun21 April 2018 10:30 AM ISTMumbai: Indian pharmaceutical formulators are expected to continue to make investments in consumer healthcare, wellness products, and traditional OTC...
NABL working towards calibration of medical equipments Ruby Khatun Khatun20 April 2018 2:57 PM ISTNew Delhi: The National Accreditation Board For Laboratories (NABL) is working towards calibration of medical equipments in the country to bring in...
WHO recommends testing before use of Sanofi's dengue vaccine Ruby Khatun Khatun20 April 2018 10:30 AM ISTPARIS/CHICAGO: The World Health Organization (WHO) said Sanofi’s vaccine against dengue should only be used after testing on individuals to assess...
Fortis Update: Munjals, Burmans better their offer, BLK promoter likely to bid Ruby Khatun Khatun19 April 2018 6:16 PM ISTNew Delhi: Fortis Healthcare said it has received an improved binding offer from Hero Enterprise Investment Office and Burman Family Office to invest...
Lupin gets tentative USFDA nod to market testosterone gel Ruby Khatun Khatun19 April 2018 10:00 AM ISTMumbai: Drug firm Lupin said it has received the tentative nod from the US health regulator to market its Testosterone gel 1.62 percent.The company...
Doctors, medical professionals highest paid in India: Report Ruby Khatun Khatun18 April 2018 5:05 PM ISTNew Delhi: Bangalore is the highest paying city in the country, while pharma and healthcare is the highest paying industry for talent in India, a...
Another Suitor in Line for Fortis, this time a Chinese Conglomerate Ruby Khatun Khatun18 April 2018 10:05 AM ISTFortis Healthcare Ltd said Fosun International Ltd has offered to invest up to $350 million, making the Chinese conglomerate the fourth suitor aiming...
Maximum 24 percent Margin on Scheduled drugs, 30 on Non scheduled: NITI Aayog Ruby Khatun Khatun17 April 2018 5:44 PM ISTNew Delhi: NITI Aayog has recommended a cap on trade margins charged by drug stockiest and chemist in order to reduce the prices of drugs while...
Govt to define stem cells as DRUG, regulate use in therapy Ruby Khatun Khatun16 April 2018 4:48 PM ISTNew Delhi: Ministry Of Health and Family Welfare has proposed the further amendment to the Drugs and Cosmetics Act bringing down the stem cells under...
Mosquitoes, gnats in Plant; no quality control: USFDA investigators Observe on Alkem Plant Ruby Khatun Khatun15 April 2018 12:21 PM ISTNew Delhi: The USFDA investigators has found mosquitoes and gnats in the manufacturing unit of Alkem Laboratories Ltd at Daman during a recent...
HDFC looks to buy Apollo Munich insurance for Rs 1,000 crore Ruby Khatun Khatun15 April 2018 9:00 AM ISTNew Delhi: HDFC is in discussion to buy Apollo Munich Health Insurance Company for an approximate valuation of Rs 1,000 crore, a recent report in ET...
